Technology of pre-programmable insulin delivery systems: continuous subcutaneous insulin infusion. 1979

J C Pickup, and H Keen, and J A Parsons, and K G Alberti

Dual-rate continuous subcutaneous insulin infusion was performed with a specially adapted Mill Hill Infuser. The infuser delivers 2 rates, a slow rate of ca. 50 microliter/h and an eightfold higher rate, designed to cover the increased requirement during meals. The high rate is engaged by pressing a button on the side of the pump, and returns automatically to the basal level after 17 min. Insulin is delivered to the subcutaneous side by a nylon cannula.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003925 Diabetic Angiopathies VASCULAR DISEASES that are associated with DIABETES MELLITUS. Diabetic Vascular Complications,Diabetic Vascular Diseases,Microangiopathy, Diabetic,Angiopathies, Diabetic,Angiopathy, Diabetic,Diabetic Angiopathy,Diabetic Microangiopathies,Diabetic Microangiopathy,Diabetic Vascular Complication,Diabetic Vascular Disease,Microangiopathies, Diabetic,Vascular Complication, Diabetic,Vascular Complications, Diabetic,Vascular Disease, Diabetic,Vascular Diseases, Diabetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J C Pickup, and H Keen, and J A Parsons, and K G Alberti
September 1989, JAMA,
J C Pickup, and H Keen, and J A Parsons, and K G Alberti
June 2011, Revista de enfermeria (Barcelona, Spain),
J C Pickup, and H Keen, and J A Parsons, and K G Alberti
January 2000, Diabetes care,
J C Pickup, and H Keen, and J A Parsons, and K G Alberti
December 2011, Acta medica portuguesa,
J C Pickup, and H Keen, and J A Parsons, and K G Alberti
November 1997, Nihon rinsho. Japanese journal of clinical medicine,
J C Pickup, and H Keen, and J A Parsons, and K G Alberti
November 1989, Nihon rinsho. Japanese journal of clinical medicine,
J C Pickup, and H Keen, and J A Parsons, and K G Alberti
December 1990, Nihon rinsho. Japanese journal of clinical medicine,
J C Pickup, and H Keen, and J A Parsons, and K G Alberti
January 2003, Diabetes care,
J C Pickup, and H Keen, and J A Parsons, and K G Alberti
January 2004, Diabetes care,
J C Pickup, and H Keen, and J A Parsons, and K G Alberti
September 1979, Lancet (London, England),
Copied contents to your clipboard!